[PDF][PDF] Severe COVID-19 Shares a Common Neutrophil Activation Signature with Other Acute Inflammatory States. Cells 2022, 11, 847

LF Schimke, AHC Marques, GC Baiocchi… - 2022 - observatorio.fm.usp.br
Severe COVID-19 patients present a clinical and laboratory overlap with other
hyperinflammatory conditions such as hemophagocytic lymphohistiocytosis (HLH) …

COVID-19 and pembrolizumab-induced secondary hemophagocytic lymphohistiocytosis: a case report

L Ramos-Ruperto, C Busca-Arenzana… - SN Comprehensive …, 2021 - Springer
Our case highlights SARS-CoV-2 and pembrolizumab as trigger of secondary
hemophagocytic lymphohistiocytosis. Although it is a rare complication, it must be suspected …

Behandlung der hämophagozytischen Lymphohistiozytose bei Patienten auf der Intensivstation

DA Eichenauer, P La Rosée - Die Innere Medizin, 2023 - Springer
Die hämophagozytische Lymphohistiozytose (HLH) ist ein hyperferritinämisches
Hyperinflammationssyndrom. Es wird eine hereditäre von einer erworbenen Form …

Multi-layered transcriptomic analyses reveal an immunological overlap between COVID-19 and hemophagocytic lymphohistiocytosis associated with disease severity

LF Schimke, AH Marques, GC Baiocchi, CA Prado… - 2021 - pesquisa.bvsalud.org
Severe COVID-19 patients present a clinical and laboratory overlap with other
hyperinflammatory conditions such as hemophagocytic lymphohistiocytosis (HLH) …

Multicentric Study on the Effect of Rectal Ozone on COVID-19: the Spanish and Slovakian Experience.

M Fernández-Cuadros, MJ Albaladejo-Florín… - 2022 - preprints.org
Objective: To evaluate the effect of rectal Ozone (O3) in severe COVID-19 pneumonia in two
different cohorts differing in location (Madrid vs Zilina), ethnicity (Slovakian vs Spanish …

[HTML][HTML] Hemophagocytic Lymphohistiocytosis Trigged by COVID-19 Infection: Case Report and Review of the Literature

F Hammami, M Koubaa, K Rekik… - Journal of Applied …, 2021 - journals.lww.com
The outbreak of the novel coronavirus-19 (COVID-19) rapidly grew into a worldwide
pandemic. The link between the disease severity and higher levels of inflammatory markers …

Simple Combined Clinical and Laboratory Markers of Hyperinflammation Predict Adverse Outcomes in Hospitalised Patients with Covid-19 and Suggest …

AE Oppong, L Coelewij, M Hutchinson, B Carpenter… - papers.ssrn.com
Background: Dexamethasone is currently recommended for use in all patients with COVID-
19 requiring supplemental oxygen, however, only some patients develop hyperinflammation …

[HTML][HTML] Cyclosporin A

S Tanga, S Lia, S Zhenga, Y Dinga, D Zhua, C Sunb… - ku-55933inhibitor.com
Macrophage activation syndrome (MAS) is a potentially life-threatening complication of
systemic autoin-flammatory/autoimmune diseases, generally systemic juvenile idiopathic …

[PDF][PDF] Evaluation of Outcome in Patients With Moderate and Severe COVID-19 Via H-Score

S Tehrani, H Shabanpour Dehbaneh… - International Journal of …, 2022 - academia.edu
Background: Due to uncontrolled lymphocyte reaction, the overproduction of cytokines in
COVID-19 patients can cause sepsis-like symptoms, suggesting sepsis, cytokine release …

[引用][C] Hemophagocytic Lymphohistiocytosis and Macrophage Activation Syndrome

HA Gans, DB Lewis - Principles and Practice of Pediatric Infectious …, 2023 - Elsevier